Lightship utilizes inclusive technology and flexible visit options to enhance patient participation in clinical trials, removing geographic barriers and providing personalized support throughout the research process. This approach addresses the limited access and choice often faced by patients and providers, accelerating the development of new therapies for diverse populations.
Funding
$108.6M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Founders
Product
Problem
Traditional clinical trials often face challenges in enrolling diverse patient populations due to geographic limitations, lack of patient choice, and other barriers. This can lead to delays in the development of new therapies and limit the applicability of research findings to broader patient groups.
Solution
Lightship offers a community-based clinical trial solution designed to improve access, choice, and equity in clinical research. The company partners with healthcare providers and clinical sites to deliver decentralized and hybrid clinical trials, expanding patient reach beyond traditional brick-and-mortar settings. By using inclusive technology, offering flexible visit options, and focusing on cultural competence, Lightship aims to accelerate the development of better treatment options for all people. Their approach supports outreach and recruitment, home nursing, and mobile research units to improve patient participation and retention.
Target Audience
Lightship primarily serves biopharmaceutical sponsors, academic institutions, and CROs seeking to conduct inclusive clinical trials with diverse patient populations, as well as healthcare providers and clinical sites looking to expand their research capabilities.
Features
- Decentralized trial design to remove geographic barriers and increase patient access
- Hybrid trial capabilities combining remote offerings with a curated network of experienced investigators and sites
- Mobile research units for conducting engagement, pre-screening, and study visits in community settings
- Home nursing services to deliver consistent and high-quality care at patients' homes or alternative locations
- Targeted community-based outreach model for faster enrollment of representative populations
- Patient retention programs that provide over 20% better retention rates compared to traditional trials